Cargando…

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

BACKGROUND: Overexpression of syndecan-1 (CD138) in breast carcinoma correlates with a poor prognosis and an aggressive phenotype. The objective of this study was to evaluate the potential of targeting CD138 by immuno-PET imaging and radioimmunotherapy (RIT) using the antihuman syndecan-1 B-B4 mAb r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rousseau, Caroline, Ruellan, Anne Lise, Bernardeau, Karine, Kraeber-Bodéré, Françoise, Gouard, Sebastien, Loussouarn, Delphine, Saï-Maurel, Catherine, Faivre-Chauvet, Alain, Wijdenes, John, Barbet, Jacques, Gaschet, Joëlle, Chérel, Michel, Davodeau, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250983/ https://www.ncbi.nlm.nih.gov/pubmed/22214534 http://dx.doi.org/10.1186/2191-219X-1-20

Ejemplares similares

Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
por: Fichou, Nolwenn, et al.
Publicado: (2015)

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction
por: Ménager, Jérémie, et al.
Publicado: (2015)

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013)

Sensitivity of pretargeted immunoPET using (68)Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with (18)FDG PET-CT
por: Foubert, Fanny, et al.
Publicado: (2018)

A pretargeting system for tumor PET imaging and radioimmunotherapy
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

Alpha Particles Induce Autophagy in Multiple Myeloma Cells
por: Gorin, Jean-Baptiste, et al.
Publicado: (2015)

Cell Tracking in Cancer Immunotherapy
por: Perrin, Justine, et al.
Publicado: (2020)

Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease
por: Gouard, Sébastien, et al.
Publicado: (2020)

Phytochemistry and Cytotoxic Activity of Aquilaria crassna Pericarp on MDA-MB-468 Cell Lines
por: Nguyen, Thao Thi Thu, et al.
Publicado: (2023)

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
por: Bodet-Milin, Caroline, et al.
Publicado: (2015)

Innovative radiopharmaceuticals in oncology and neurology
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2017)

PRIMA-1(MET) Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023)

The growth inhibitory effects of cadmium and copper on the MDA-MB468 human breast cancer cells
por: Panjehpour, Mojtaba, et al.
Publicado: (2010)

Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells
por: Kil, Won Ho, et al.
Publicado: (2014)

Optimal Electroporation Condition for Small Interfering RNA Transfection into MDA-MB-468 Cell Line
por: Arabsolghar, Rita, et al.
Publicado: (2012)

Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cells
por: Borrego, Stacey L., et al.
Publicado: (2016)

Pretargeting for imaging and therapy in oncological nuclear medicine
por: Bailly, Clément, et al.
Publicado: (2017)

Comparison of Immuno-PET of CD138 and PET imaging with (64)CuCl(2) and (18)F-FDG in a preclinical syngeneic model of multiple myeloma
por: Bailly, Clément, et al.
Publicado: (2018)

Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines
por: Vargas Casanova, Yerly, et al.
Publicado: (2017)

Silencing of Nucleostemin by siRNA Induces Apoptosis in MCF-7 and MDA-MB-468 Cell Lines
por: Moudi, Mahdiyeh, et al.
Publicado: (2020)

Cytotoxicity of different extracts of arial parts of Ziziphus spina-christi on Hela and MDA-MB-468 tumor cells
por: Jafarian, Abbas, et al.
Publicado: (2014)

Overexpressing modified human TRβ1 suppresses the proliferation of breast cancer MDA-MB-468 cells
por: Peng, Xiaoxiang, et al.
Publicado: (2018)

Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Alsrhani, Abdullah, et al.
Publicado: (2023)

What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between (89)Zr- and (64)Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model
por: Bailly, Clément, et al.
Publicado: (2019)

Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2021)

ImmunoPET to help stratify patients for targeted therapies and to improve drug development
por: Kraeber-Bodere, Françoise, et al.
Publicado: (2016)

Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA–In)
por: Rauscher, Aurore, et al.
Publicado: (2015)

Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway
por: Zhou, Qianmei, et al.
Publicado: (2019)

Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468
por: Ashourpour, Maryam, et al.
Publicado: (2021)

β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells
por: Di Sotto, Antonella, et al.
Publicado: (2022)

Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies
por: Berdal, Marion, et al.
Publicado: (2020)

ImmunoPET in Multiple Myeloma—What? So What? Now What?
por: Bailly, Clément, et al.
Publicado: (2020)

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology
por: Barbet, Jacques, et al.
Publicado: (2017)

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging
por: Colombié, Mathilde, et al.
Publicado: (2015)

Challenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2014)

Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
por: Shafiee, Fateme, et al.
Publicado: (2012)

Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib
por: WANG, XINZHAO, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a84klr5s80dujjalvn28um83lp